NEXGEL (NXGL) Competitors $2.22 -0.12 (-5.13%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$2.22 -0.01 (-0.23%) As of 05/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXGL vs. OM, EDAP, NSPR, BSGM, VANI, CTCX, NTRB, SURG, ICCM, and APYXShould you be buying NEXGEL stock or one of its competitors? The main competitors of NEXGEL include Outset Medical (OM), Edap Tms (EDAP), InspireMD (NSPR), BioSig Technologies (BSGM), Vivani Medical (VANI), Carmell (CTCX), Nutriband (NTRB), SurgePays (SURG), IceCure Medical (ICCM), and Apyx Medical (APYX). These companies are all part of the "medical equipment" industry. NEXGEL vs. Outset Medical Edap Tms InspireMD BioSig Technologies Vivani Medical Carmell Nutriband SurgePays IceCure Medical Apyx Medical Outset Medical (NASDAQ:OM) and NEXGEL (NASDAQ:NXGL) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability. Does the MarketBeat Community prefer OM or NXGL? Outset Medical received 24 more outperform votes than NEXGEL when rated by MarketBeat users. However, 50.00% of users gave NEXGEL an outperform vote while only 37.88% of users gave Outset Medical an outperform vote. CompanyUnderperformOutperformOutset MedicalOutperform Votes2537.88% Underperform Votes4162.12% NEXGELOutperform Votes150.00% Underperform Votes150.00% Which has better earnings and valuation, OM or NXGL? NEXGEL has lower revenue, but higher earnings than Outset Medical. NEXGEL is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOutset Medical$115.27M0.58-$172.80M-$29.15-0.64NEXGEL$10.23M1.66-$3.16M-$0.45-4.93 Do institutionals & insiders have more ownership in OM or NXGL? 2.2% of NEXGEL shares are held by institutional investors. 2.4% of Outset Medical shares are held by insiders. Comparatively, 20.5% of NEXGEL shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is OM or NXGL more profitable? NEXGEL has a net margin of -52.60% compared to Outset Medical's net margin of -112.57%. NEXGEL's return on equity of -71.19% beat Outset Medical's return on equity.Company Net Margins Return on Equity Return on Assets Outset Medical-112.57% -175.64% -38.61% NEXGEL -52.60%-71.19%-34.79% Which has more risk and volatility, OM or NXGL? Outset Medical has a beta of 1.9, meaning that its share price is 90% more volatile than the S&P 500. Comparatively, NEXGEL has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Do analysts recommend OM or NXGL? Outset Medical currently has a consensus price target of $27.00, indicating a potential upside of 45.16%. Given Outset Medical's stronger consensus rating and higher possible upside, analysts plainly believe Outset Medical is more favorable than NEXGEL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Outset Medical 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00NEXGEL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor OM or NXGL? In the previous week, Outset Medical had 3 more articles in the media than NEXGEL. MarketBeat recorded 7 mentions for Outset Medical and 4 mentions for NEXGEL. Outset Medical's average media sentiment score of 0.07 beat NEXGEL's score of -0.08 indicating that Outset Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Outset Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NEXGEL 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryNEXGEL beats Outset Medical on 10 of the 19 factors compared between the two stocks. Get NEXGEL News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNEXGELSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.99M$4.49B$5.37B$8.39BDividend YieldN/A43.63%5.22%4.10%P/E Ratio-3.8329.4326.8419.71Price / Sales1.6667.72392.34117.39Price / CashN/A51.0838.2534.62Price / Book2.476.236.794.50Net Income-$3.16M$68.16M$3.23B$248.18M7 Day Performance-6.33%-0.19%1.53%0.20%1 Month Performance-19.57%19.19%10.05%12.37%1 Year Performance-4.72%21.47%16.71%7.04% NEXGEL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNEXGEL0.918 of 5 stars$2.22-5.1%N/A-1.8%$16.99M$10.23M-3.8310Gap DownOMOutset Medical1.3617 of 5 stars$19.58+0.4%$24.67+26.0%-66.3%$70.39M$115.27M-7.90520Analyst ForecastGap DownHigh Trading VolumeEDAPEdap Tms1.8223 of 5 stars$1.86+5.7%$8.50+357.0%-71.0%$69.55M$64.12M-2.86230Earnings ReportAnalyst RevisionGap DownNSPRInspireMD2.2412 of 5 stars$2.26-4.2%$4.50+99.1%-4.7%$69.24M$7.03M-3.0150Gap UpBSGMBioSig Technologies0.3674 of 5 stars$2.85+9.2%$2.50-12.3%+79.3%$69.12M$40,000.000.0050Earnings ReportGap UpVANIVivani Medical3.1262 of 5 stars$1.07+3.9%$4.00+273.8%-36.7%$63.39MN/A-2.3820News CoverageAnalyst ForecastCTCXCarmellN/A$3.00-2.8%N/A+35.8%$62.72M$32,839.000.0014NTRBNutriband2.1833 of 5 stars$5.71+1.6%$13.00+127.7%+9.2%$62.69M$2.14M-8.0410Positive NewsSURGSurgePays2.8404 of 5 stars$2.91+2.1%$8.75+200.7%-22.4%$59.40M$60.88M-2.5840ICCMIceCure Medical2.0808 of 5 stars$1.03-1.4%$2.50+143.9%-5.5%$56.89M$3.29M-3.5360News CoveragePositive NewsUpcoming EarningsAPYXApyx Medical0.7735 of 5 stars$1.49+4.2%N/A-7.5%$54.05M$47.29M-1.80270 Related Companies and Tools Related Companies OM Alternatives EDAP Alternatives NSPR Alternatives BSGM Alternatives VANI Alternatives CTCX Alternatives NTRB Alternatives SURG Alternatives ICCM Alternatives APYX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGL) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NEXGEL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NEXGEL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.